Frequency of molecular response in a patient of chronic myeloid leukemia taking Tyrosine Kinase Inhibitors after 1 year of treatment Pakistan Institute of Medical Sciences experience. Med J South Punjab. 2025;6(01):20-25. doi:10.61581/MJSP.VOL06/01/04